A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
Status:
Completed
Trial end date:
2018-10-22
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate whether the study drug known as abemaciclib is
effective in treating participants with breast cancer who have already tried other drug
treatments.